Pharma Outsourcing - The Online Scientific Community

Life Technologies' OpTmizer™ T-Cell Growth Medium Receives FDA Clearance
Friday, September 28, 2012
Offers cost- and time-saving advantages and is now cleared as a Class II medical device.

NanoString Launches Single Cell Gene Expression Solution for its nCounter® Analysis System
Wednesday, September 26, 2012
New protocol enables scientists to investigate more genes than microfluidic qPCR protocols with high sensitivity.

ATLAS Biolabs is Awarded Certified Service Provider Accreditation from Affymetrix for DMET Analysis
Tuesday, September 25, 2012
DMET Plus uses microarray testing to investigate common variations in genes encoding for drug-metabolism enzymes and drug transporters, and to identify their impact on the individual metabolic capacity.

New Taste-Masking Technologies Facilitate User-Friendly Pharmaceuticals
Wednesday, September 12, 2012
Hermes Pharma, INNOJET Herbert Hüttlin, RCPE and Karl Franzens University research new approaches to increase patient compliance and improve production processes.

Molecular Devices to attend HET Instrument and Scanlab 2012
Tuesday, September 11, 2012
Amsterdam, The Netherlands. 25th – 28th September 2012 and Copenhagen, Denmark. 25th – 27th September 2012.

Spot On Sciences Launches Searchable Database of Dried Blood Spot Methods
Friday, September 07, 2012
Spot On Science’s free, publicly accessible database aids researchers by providing rapid access to published dried blood spot (DBS) test methods.

ACD/Labs’ Strengthens its Presence in China with CROs
Tuesday, August 28, 2012
One of China’s leading pharmaceutical contract research organizations is providing each of their thousands of chemists in China with ACD/NMR Processor software.

New Appel Consulting Website is Now Live
Friday, August 24, 2012
The world pharmaceutical community now has access to a multilingual website, in English, French, Spanish, German, Arabic, Swedish and Italian to name but a few!

BASF subsidiary Metanomics Health launches MetaMap®Tox
Monday, August 13, 2012
MetaMap®Tox is a service evaluating specific metabolomic patterns in vivo, enabling customers to better and faster identify potential safety risks of test compounds in in vivo studies of rats. Developed in-house by BASF’s Experimental Toxicology and Ecology unit and marketed through Metanomics Health, MetaMap®Tox addresses key unmet needs for in vivo toxicology testing: predictability, understanding of a toxicology mechanism and the ability for translation to clinical use.

<<	1 2 3 4 5 6 7	>>
Showing Results 11 - 20 of 226

Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.